Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?

Hepato-gastroenterology - 1 Jan 2000

Tahan Veysel, Ozaras Resat, Karaca Cetin, Uraz Suleyman, Eren Fatih, Danalioglu Ahmet, Avsar Erol, Turkoglu Salih, Midilli Kenan, Tabak Fehmi, Ozturk Recep, Mert Ali, Senturk Hakan, Tozun Nurdan

Abstract excerpt

BACKGROUND/AIMS: The management of chronic hepatitis C virus (HCV) infection is costly. Genotyping determines the indication, probability of response, and duration of treatment and the dose of ribavirin. Although genotyping is accepted cost-effective, the cost of genotyping in all of the patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RNA, Viral

Source

Identifiers

PMID: 19950804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19950804-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?PMID 19950804Read ↗

THE NEED FOR HBV GENOTYPING: A COST-EFFICIENT APPROACH.Semantic proximity Read ↗

Clinical characteristics, healthcare costs, and resource utilization in hepatitis C vary by genotype.Semantic proximity Read ↗

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.Semantic proximity Read ↗

[Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of viremia?].Semantic proximity Read ↗

What is (cost) effective in patients with chronic hepatitis C virus infection?Semantic proximity Read ↗

Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirin.Semantic proximity Read ↗

Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.Semantic proximity Read ↗

[Cost-effectiveness of chronic hepatitis C treatment in Spain].Semantic proximity Read ↗

Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007.Semantic proximity Read ↗

Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisSemantic proximity Read ↗

The hepatitis C genotype 1 paradox: cost per treatment is increasing, but cost per cure is decreasing.Semantic proximity Read ↗

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.